Daniel Cohen
Co-founder, Chief Executive Officer

More than 30 years' experience in academia, biotech and big pharma companies. Professor of Medical Genetics, founder of modern genetics, genomics and pharmacogenomics. Former CSO of Genset (acquired by Serono) and VP Genetics Worldwide of Serono Genetics Institute. Co-founder of Millennium Pharma, Genethon and the CEPH research institute. Author of 150 peer-reviewed publications.

Serguei Nabirotchkin
Co-founder, Chief Biology Officer

Specialist in experimental genetics, cell signaling and systems biology. Graduated from the Moscow State University, former leader scientist at the Institute of Molecular Biology in Moscow (Russia), DKFZ (Germany), Gustave Roussy Institute (France) and Genset (France). Former Director of the Animal Model Department at the Serono Genetics Institute.

Amit Kohli
Chief Operating Officer

Business leader for over 20 years across pharmaceutical, medtech and clinical diagnostic sectors. Previously worked as General Manager, Clinical Diagnostics at Eurofins leading strategy and operations. Deep cross functional expertise based on numerous leadership roles across P&L management, sales, marketing, finance, supply chain, manufacturing gained at Becton Dickinson & Sanofi.

Xavier Paoli
VP, Chief Commercial Officer

Held various marketing positions in biotech and big pharma companies (GlaxoSmithKline, UCB Pharma, Alexion). Brings 15 years of experience in the commercialization of innovative drugs notably for rare diseases. Graduated from HEC Paris with a Master of Marketing and from the University Paris 7 with Masters of Science in Genetics and Immunology.


René Goedkoop
Chief Medical Officer

More than 25 years' of experience in clinical product development for inflammatory diseases including rare CNS disorders, cancer and cardiovascular diseases in start-up and large biopharmaceutical companies (Centocor, Eli Lilly, Serono, Modex, Apoxis). As an independent consultant, he conducted due diligences and helped develop business plans for de novo biotech companies.

Rodolphe Hajj
Chief Pharmacology Officer

More than 15 years' experience in fundamental research and drug discovery & development in stem cells, respiratory research, cystic fibrosis, cancer and neurology in academia and industry. He was in charge of the Cancer Stem Cell project at Sanofi, then led at Servier the High Content Cellular imaging platform for different disease areas.

Catherine Chalandon

More than 15 years' experience in biotech sector. Former manager at Bionest Partners, a corporate finance and strategy consultancy group specialized in life sciences. Previously in Life Sciences team at Robertson Stephens and Bank of America Securities in London, UK. Graduated from HEC Paris after completing a Master's degree in management with a specialization in finance.